An Optimized Peptide Antagonist of CXCR4 Limits Survival of BCR–ABL1-Transformed Cells in Philadelphia-Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia

Johanna Pohl(Universität Ulm), Moumita Datta(University Hospital Ulm)

International Journal of Molecular Sciences

July 30, 2024

10.3390/ijms25158306

Cited by 8

Related Papers

No related papers found

Powered by citation graph analysis